Association of ischemia on stress 99mTc-tetrofosmin myocardial perfusion imaging with all-cause mortality in patients with diabetes mellitus

Journal of Nuclear Medicine

Volumn 46, Issue 10, 2005, Pages 1589-1595

  Elhendy, Abdou ^a,b,d   Huurman, Aukje ^a   Schinkel, Arend F L ^a   Bax, Jeroen J ^c   Van Domburg, Ron T ^a   Valkema, Roelf ^a   Biagini, Elena ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Coronary artery disease; Diabetes mellitus; Risk stratification

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; ANAMNESIS; ARTICLE; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EXERCISE TEST; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; COMORBIDITY; METHODOLOGY; MIDDLE AGED; MORTALITY; NETHERLANDS; PREVALENCE; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS; SURVIVAL; SURVIVAL RATE;

CAUSE OF DEATH; COMORBIDITY; DIABETES MELLITUS; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NETHERLANDS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PREVALENCE; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 33644667136     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J. Multiple risk factor intervention trial research group: impact of diabetes and previous myocardial infarction on long-term survival-25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med. 2003;164:1438-1443.
2. Lowe LP, Greenland P, Ruth KJ, Dyer AR, Stamler R, Stamler J. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Intern Med. 1998;158:2007-2014.
3. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu EB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002;40:954-960.
4. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001;161:1717-1723.
5. Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands. Eur J Epidemiol. 2003;18:793-800.
6. Morgan CL, Currie CJ, Peters JR. Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care. 2000;23:1103-1107.
7. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998;21:1138-1145.
8. Laing SP, Swerdlow AJ, Slater SD, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2002;46:760-765.
9. Haffner SM, Lehto S, Rename T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
10. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134-1146.
11. American Diabetes Association. Consensus Development Conference on the Diagnosis of Coronary Heart Disease in People with Diabetes: 10-11 February 1998, Miami, Florida. Diabetes Care. 1998;21:1551-1559.
12. Elhendy A, Arruda AM, Mahoney DW, Pellikka PA. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol. 2001;37:1551-1557.
13. Bigi R, Decider A, Cortigiani L, Bax JJ, Celeron L, Florentine C. Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care. 2001;24:1596-1601.
14. Sozzi FB, Elhendy A, Roelandt JR, et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care. 2003;26:1074-1078.
15. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation. 2000;101:1465-1478.
16. Kang X, Berman DS, Lewin HC, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J. 1999;138:1025-1032.
17. Felsher J, Eisner MD, Hake AH, Heo J, Kane-March S, Iskandrian AS. Exercise thallium imaging in patients with diabetes mellitus. Arch Intern Med. 1987;147:313-317.
18. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms of coronary artery disease. Circulation. 2002;105:32-40.
19. Schinkel AF, Elhendy A, van Domburg RT, et al. Prognostic value of dobutamine-atropine stress myocardial perfusion imaging in patients with diabetes. Diabetes Care. 2003;25:1637-1643.
20. Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men: impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125-1133.
21. Cohen MC, Curran PJ, L'Italien GJ, Mittleman MA, Zarich SW. Long-term prognostic value of preoperative dipyridamole thallium imaging and clinical indexes in patients with diabetes mellitus undergoing peripheral vascular surgery. Am J Cardiol. 1999;83:1038-1042.
22. Vanzetto G, Halimi S, Hammoud T, et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients: prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care. 1999;22:19-26.
23. Lauer MS, Blackstone EH, Young JB, Tool EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34:618-620.
24. Zgibor JC, Songer TJ, Kelsey SF, Drash AL, Orchard TJ. Influence of health care providers on the development of diabetes complications: long-term follow-up from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2002;25:1584-1590.
25. Elhendy A, Schinkel AF, Van Domburg RT, Bax JJ, Poldermans D. Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging. J Hypertens. 2003;21:1945-1951.
26. Elhendy A, Schinkel AF, Van Domburg RT, Bax JJ, Valkema R, Poldermans D. Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: impact of scintigraphic extent of coronary artery disease. J Nucl Cardiol. 2004;11:704-709.
27. Lund-Johansen P. Blood pressure response during exercise as a prognostic factor. J Hypertens. 2003;20:1473-1475.
28. Geleijnse ML, Elhendy A, van Domburg RT, et al. Prognostic significance of systolic blood pressure changes during dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain and known or suspected coronary artery disease. Am J Cardiol. 1997;79:1031-1035.
29. Giannuzzi P, Marcassa C, Temporelli PL, et al. Residual exertional ischemia and unfavorable left ventricular remodeling in patients with systolic dysfunction after anterior myocardial infarction. J Am Coll Cardiol. 1995;25:1539-1546.
30. Barrabes JA, Garcia-Dorado D, Gonzalez MA, et al. Regional expansion during myocardial ischemia predicts ventricular fibrillation and coronary reocclusion. Am J Physiol. 1998;274:H1767-H1775.
31. Behrens S, Li C, Franz MR. Effects of myocardial ischemia on ventricular fibrillation inducibility and defibrillation efficacy. J Am Coll Cardiol. 1997;29:817-824.
32. Bell DS. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care. 2003;26:2433-2441.
33. Breton AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care. 2004;27:699-703.
34. Jude EB, Ohio SO, Chalmers N, Bolton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2000;24:1433-1437.
35. Wackers FJ, Young LH, Induct SE, et al. Detection of Ischemia in Asymptomatic Diabetics investigators: detection of silent myocardial ischemia in asymptomatic diabetic subjects-The DIAD study. Diabetes Care. 2004;27:1954-1961.
36. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care. 1999;22:1396-1400.
37. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol. 2005;45:43-49.
38. Lee J, Chae SC, Lee K, Heo J, Iskandrian AS. Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise. J Nucl Med. 1994;35:535-541.
39. Tadamura E, Iida H, Matsumoto K, et al. Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men. J Am Coll Cardiol. 2001;37:130-136.
40. Elhendy A, Bax JJ, Poldermans D. Dobutamine stress myocardial perfusion imaging in coronary artery disease. J Nucl Med. 2002;43:1634-1646.